NCT03204981View on ClinicalTrials.gov

Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

April 20, 2021

Study Completion Date

April 20, 2021

Conditions
Ventricular Arrythmia
Interventions
DEVICE

Intramural Needle Ablation

The needle-tipped ablation catheter that will be used for the IN ablation uses radiofrequency like a standard RF ablation catheter, but delivers energy through an extendable/retractable needle.

PROCEDURE

Ablation

standard ablation

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

Biosense Webster, Inc.

INDUSTRY

lead

Vivek Reddy

OTHER

NCT03204981 - Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias | Biotech Hunter | Biotech Hunter